Article
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
Pathology - 1 Feb 2022
Gángó Ambrus, Kiss Richárd, Farkas Péter, Hanna Eid, Demeter Judit, Deák Beáta, Lévai Dóra, Kotmayer Lili, Alpár Donát, Matolcsy András, Bödör Csaba, Mátrai Zoltán, Timár Botond
Abstract excerpt
Richter syndrome (RS) represents the development of high-grade lymphoma in patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) and presents a diagnostic and therapeutic challenge with an adverse prognosis. The genetic background and morphology of RS in CLL patients treated with chemoimmunotherapy is extensively characterised; however, our knowledge about RS in patients treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.